Compare · MODD vs SYK
MODD vs SYK
Side-by-side comparison of Modular Medical Inc. (MODD) and Stryker Corporation (SYK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MODD and SYK operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- SYK is the larger of the two at $129.09B, about 10323.8x MODD ($12.5M).
- Over the past year, MODD is down 88.9% and SYK is down 16.0% - SYK leads by 72.9 points.
- MODD has been more active in the news (4 items in the past 4 weeks vs 2 for SYK).
- SYK has more recent analyst coverage (25 ratings vs 0 for MODD).
- Company
- Modular Medical Inc.
- Stryker Corporation
- Price
- $2.34-6.40%
- $336.70+1.92%
- Market cap
- $12.5M
- $129.09B
- 1M return
- -43.07%
- +6.50%
- 1Y return
- -88.86%
- -15.96%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 4
- 2
- Recent ratings
- 0
- 25
Modular Medical Inc.
Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California.
Stryker Corporation
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Latest MODD
- Modular Medical Announces Formation of Pivot Innovation Council and Appointment of Robert Gabbay, MD, PhD, FACP as Chairman
- Modular Medical and IMO Health Launch Strategic Pilot to Enable Real Time Insulin Pump Patient Identification Into Electronic Health Records
- Modular Medical Receives Research Demonstrating Positive Payor Reception of Pivot Tubeless Patch Pump
- Modular Medical Announces Completion of Research Initiative Indicating Strong Interest in Simpler Insulin Delivery
- SEC Form 4 filed by Director Vos Ellen O'Connor
- SEC Form 4 filed by Director Sheibley Philip Brent
- SEC Form 4 filed by Director Goldberg Jeff D
- Director Felsher Steven G was granted 25 shares, increasing direct ownership by 0.30% to 8,498 units (SEC Form 4)
- Director Volkart Carmen B was granted 110 shares, increasing direct ownership by 14% to 916 units (SEC Form 4)
- Director Desisto Duane M was granted 83 shares, increasing direct ownership by 0.97% to 8,627 units (SEC Form 4)
Latest SYK
- Stryker expands Mako robotics portfolio with full market release of Mako RPS
- BMO Capital Markets initiated coverage on Stryker with a new price target
- Stryker to announce second quarter 2026 financial results
- Stryker Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Stryker partners with professional golfer Shane Lowry to spotlight the caregiver journey in joint replacement
- Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower
- President and COO Stiles Spencer S gifted 1,607 shares, decreasing direct ownership by 2% to 76,027 units (SEC Form 4)
- Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures
- VP, Chief Legal Officer Fletcher Robert S sold $1,394,409 worth of shares (4,544 units at $306.87) as part of a pre-agreed trading plan, decreasing direct ownership by 30% to 10,582 units (SEC Form 4)
- Director Stryker Ronda E sold $96,792,669 worth of shares (310,000 units at $312.23) (SEC Form 4)